Search

Poly Medicure

Sector: Healthcare | Industry: Drugs & Pharma
R 209.65 -1.70  | -0.80% -6.84% 25.70 1,875.25
NSE Price: Oct 18, 15:42 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 15:42 209.65 -1.70 -0.80% 210.00 211.35 2,107 208.00 - 212.65
BSE Oct 18, 2019 212.50 -0.35 -0.16% 208.00 212.85 11 208.00 - 212.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 7,767 P/B: 4.69 NSE Code: POLYMED
52-Week Range: R 165.10 - 252.85 Dividend Yield: 0.94% BSE Code: 531768
TTM EPS: R 8.27 Book Value: R 45.29 Face Value: R 5
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Poly Medicure -3.98 1.17 19.01 -6.58 3.57 1.11 41.22
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 17.37 14.00 13.64
Net Profit -7.72 10.47 7.77
EPS -7.37 10.65 7.69
Book Value 12.77 18.56 21.12
Average
Operating Margin 24.51 24.74 24.33
Net Margin 10.17 11.59 12.31
Return on Networth 17.80 20.79 24.15
Return on Investment 22.19 23.98 27.29
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -4.70 15.98 -4.70
Operating Profit 1.78 18.23 1.78
Net Profit -6.05 48.19 -6.05
EPS -6.06 48.15 -6.06
TTM
Revenue 3.58 14.14 3.58
Operating Profit 4.26 8.80 4.26
Net Profit 9.89 1.62 9.89
EPS 9.88 1.60 9.88
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Poly Medicure 1,875.25 607.68 72.96 11.69 17.80 4.69 25.70
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jul 17, 2018 Himanshu Baid  Sell Market 167,000 213.50 356.55
Jul 17, 2018 Rishi Baid  Buy Market 167,000 213.50 356.55
Apr 11, 2017 Zetta Matrix Consulting LLP  Buy Market 4,159,830 293.90 12,225.74
Mar 24, 2017 Ambuj Chandna  Buy Inter-Se Transfer 368,899 246.95 911.00
Mar 24, 2017 Ambuj Chandna  Buy Inter-Se Transfer 84,335 246.95 208.27
Review & Analysis
News & Announcements
Contact Information

Company: Poly Medicure Ltd.

Address: 232b, 3rd Floor, Okhla Industrial Estate, Phase I I I, New Delhi, Delhi - 110020 | Phone: 011 - 26321838, 81, 89, 93 | Fax: 011 – 26321839, 94

Email: [email protected]

Website: www.polymedicure.com

Registrar & Transfer Agent: MAS Services Ltd

Address: T-34, 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi - 110020, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II | Phone: 011-26387281/82/83 | Fax: 011-26387384

Website: www.masserv.com

Essential checks
Altman Z-Score
6.16
Piotroski F-Score
3
Modified C-Score
1
5-Years Price to Earnings
25.70
5-Years Price to Book
4.69
Earnings Yield
EBIT / Enterprise value
5.91%
PEG
Price / Earnings to growth ratio
2.33
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59